Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs System Labs

CoreAge Rx
Graded #1

Higher grade

vs+23.39999999999999
System Labs
Graded #89

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 68.4/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +6
92
86
Dose & formulationCoreAge Rx +36
88
52
Clinical oversightCoreAge Rx +21
93
72
Labs & monitoringCoreAge Rx +50
90
40
FulfillmentCoreAge Rx +17
95
78
Contract termsCoreAge Rx +12
96
84
CoreAge Rx · left barSystem Labs · right bar

The numbers

MetricCoreAge RxSystem Labs
WeighScore91.8/10068.4/100
GradeA−C
Scorecard rank#1#89
Semaglutide$149/moNot offered
Tirzepatide$349/mo$179/mo flat at every dose ($99 first month only, then $179)
CoverageAll 50 statesNot disclosed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
System Labs

Graded #89 · C

Strengths

  • A flat $179/mo month-to-month rate at every dose, stated in the company's own FAQ as "a flat $179/mo with no hidden fees" — there is no prepay rung to buy down to it, no membership fee and no per-visit charge on top
  • Three named physicians with checkable credentials sit on the medical board — Dr Marc Gruner (sports medicine, trained at Mayo Clinic), Dr Jonathan Hinds (board-certified emergency medicine, trained at Rutgers) and Dr Gregory Tennant (fellowship-trained orthopaedic trauma surgeon, trained at Vanderbilt) — where most of this board names nobody at all
  • Free two-day temperature-controlled shipping with injection supplies included, automatic refills on your own schedule, and pause or cancel yourself from the dashboard
  • The lander carries its own bolded disclosure that the compounded product is not FDA-approved, rather than leaving a reader to work that out afterwards

Where it loses points

  • One molecule only — the product is a compounded GLP-1/GIP built on tirzepatide, and there is no semaglutide option at any price
  • The advertised "$99" is a first-month introductory rate, labelled "/first mo." on the page itself; from month two the bill is $179, so the first charge is not the standing cost
  • Weekly subcutaneous injection only — no oral or sublingual route, and no brand-name Zepbound or Mounjaro lane
  • The states served are published nowhere; one board physician is described as licensed in all 50, which is a fact about a clinician and not a statement of where the company can dispense
  • The dispensing pharmacy is identified only as "a certified U.S. pharmacy" — never a facility, never a city, never a 503A or 503B designation
  • No lab or monitoring programme is published — nothing states whether baseline or follow-up bloodwork is required, included in the price, or billed on top of it
  • Compounded tirzepatide is not FDA-approved and is not a generic equivalent of Zepbound or Mounjaro
  • The testimonials are first-name-and-age only, and several of them praise the NAD+ and glutathione lines rather than the GLP-1 programme, so they are no evidence about this product

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard